Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gleolan (5-ALA) for Tumor Visualization in Pediatric Brain Tumor Surgery
NCT06907485Phase 2Not yet recruiting
- Start
- Aug 2027
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in brain tumor. Planned start Aug 2027; status: not yet recruiting.
02
Drugs
5-aminolevulinic acid
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT06907485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06907485.